Boehringer Ingelheim beefs up St. Joe manufacturing after merger

After closing its mega-merger with Merial this year, Boehringer Ingelheim slowly began ramping up its animal health manufacturing in St. Joseph. The company confirmed that it would increase production capacity as it transfers products from its former Fort Dodge, Iowa, facility. Elanco U.S. Inc. acquired the facility from Boehringer Ingelheim Animal Health in 2016, as well as a portfolio of its vaccine products, for $885 million as part of Boehringer Ingelheim’s acquisition of Merial. The St.…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news